The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Primary age-related tauopathy (PART): a common pathology associated with human aging
Open accessAbstract
We recommend a new term, "primary age-related tauopathy" (PART), to describe a pathology that is commonly observed in the brains of aged individuals. Many autopsy studies have reported brains with neurofibrillary tangles (NFTs) that are indistinguishable from those of Alzheimer's disease (AD), in the absence of amyloid (Aβ) plaques. For these "NFT+/Aβ-" brains, for which formal criteria for AD neuropathologic changes are not met, the NFTs are mostly restricted to structures in the medial temporal lobe, basal forebrain, brainstem, and olfactory areas (bulb and cortex). Symptoms in persons with PART usually range from normal to amnestic cognitive changes, with only a minority exhibiting profound impairment. Because cognitive impairment is often mild, existing clinicopathologic designations, such as "tangle-only dementia" and "tangle-predominant senile dementia", are imprecise and not appropriate for most subjects. PART is almost universally detectable at autopsy among elderly individuals, yet this pathological process cannot be specifically identified pre-mortem at the present time. Improved biomarkers and tau imaging may enable diagnosis of PART in clinical settings in the future. Indeed, recent studies have identified a common biomarker profile consisting of temporal lobe atrophy and tauopathy without evidence of Aβ accumulation. For both researchers and clinicians, a revised nomenclature will raise awareness of this extremely common pathologic change while providing a conceptual foundation for future studies. Prior reports that have elucidated features of the pathologic entity we refer to as PART are discussed, and working neuropathological diagnostic criteria are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Perivascular, subpial, and periventricular p-tau immunoreactive NFTs and astrocytic tangles in the neocortex have been reported to be characteristic of both primary age-related tauopathy (PART) [35] and age-related tau astrogliopathy (ARTAG) [36].”
From The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features (2017) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary age-related tauopathy (PART) and aging-related tau astrogliopathy (ARTAG) are independent tau pathologies commonly observed in patients over 80 years of age, and PART may account for a proportion of the misdiagnosed clinical AD cases in the elderly [130, 141, 142].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [142]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lesions are found in the hippocampus and adjacent regions similar to those observed in Braak I-IV, but PART is distinct from AD in that it lacks amyloid plaques, and it has distinct morbidity and age range [130, 142].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [142]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PART refers to neuronal tau pathology and ARTAG is characterized by astrocytic tau pathology, although they are not mutually exclusive, and appear to be more a manifestation of age than a subtype of neurodegenerative disease.”
From The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features (2017) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies, from the histopathology of Braak and Braak4 to longitudinal studies of Tau positron emission tomography imaging27,28, demonstrate that MTG is a transition zone between aging-related or preclinical AD-related medial temporal lobe pTau and more advanced stages of AD, where neocortical pTau extends across the brain and is strongly correlated with dementia4,29–31.”
From Integrated multimodal cell atlas of Alzheimer’s disease (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It should be noted that tau aggregation in the brain is associated with older age and is generally uncommon in healthy young adults (Braak et al., 2011; Crary et al., 2014).”
From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Crary et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LATE and PART are common neuropathologies, indicating the importance of addressing potential relationships between AD-Mimics, and LATE and PART pathology in future research (20,22).”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“AD-Mimics and definite PART are both defined as having no neuritic plaques, and like the AD-Mimics in this study, PART participants are generally older and experience less severe cognitive dysfunction (22,23).”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“The compact NFTs observed are morphologically most like those seen in primary age-related tauopathy (PART) [4], Alzheimer’s disease (AD) [22], and chronic traumatic encephalopathy (CTE) [13, 14], but the topographical distribution and immunostaining characteristics differ from these more common tauopathies in several respects.”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [4]
In the citing paper
“APOE4 significantly aggravated tau-mediated neurodegeneration in a tauopathy mouse model and induced tau aggregates in brain, while genetic ablation of APOE attenuated tau-induced neurodegeneration [469, 470].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [470]
In the citing paper
“In AD and PART, the tau aggregates are a mixture of three-repeat and four-repeat tau isoforms, whereas four-repeat sequences dominate in PSP and CBD and three-repeat sequences predominate in Pick disease14,18,19,21.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [14]
In the citing paper
“More recently, Crary et al. coined the term “primary age-related tauopathy” (PART) after observing that the postmortem brains of many elderly individuals harbor NFTs indistinguishable from those of AD but in the absence of Aβ plaques or cognitive decline [44].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [44]
In the citing paper
“The panel did not ultimately accept all of the a priori criteria for CTE; they did not include pathology known to be associated with aging (i.e.primary age-related tauopathy [PART] [16] and aging-related tau astrogliopathy [ARTAG] [17]).”
From Mild Chronic Traumatic Encephalopathy Neuropathology in People With No Known Participation in Contact Sports or History of Repetitive Neurotrauma (2019) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Self-citationMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 3×
“the current guidelines for AD [64, 102], mild Aβ plaques”
BackgroundInfluentialSelf-citationConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Cited by
Sorted by citations
Items 601–700 of 1,002
Devi, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1213968 · Cited by 29
Kim, W. H., Racine, A. M., Adluru, N., Hwang, S. J., Blennow, K., Zetterberg, H., Carlsson, C. M., Asthana, S., Koscik, R. L., Johnson, S. C., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.10.024 · Cited by 28
Wang, S. J., Guo, Y., Ervin, J. F., Lusk, J. B., & Luo, S. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02432-5 · Cited by 28
Age-, sex-, and pathology-related variability in brain structure and cognition
Bachmann, D., Buchmann, A., Studer, S. T., Saake, A., Rauen, K., Zuber, I., Gruber, E., Nitsch, R. M., Höck, C., Gietl, A. F., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02572-6 · Cited by 32
Chronic traumatic encephalopathy (CTE) in the context of longstanding intimate partner violence
Tiemensma, M., Byard, R. W., Vink, R., Affleck, A. J., Blumbergs, P. C., & Buckland, M. E. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02757-3 · Cited by 28
Xia, C., & Dickerson, B. C. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.02.005 · Cited by 28
Relative neuron loss in hippocampal sclerosis of aging and Alzheimer's disease
Ihara, R., Vincent, B. D., Baxter, M. R., Franklin, E. E., Hassenstab, J. J., Xiong, C., Morris, J. C., & Cairns, N. J. (2018) · Annals of Neurology · doi:10.1002/ana.25344 · Cited by 28
Self-citationAbbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Poloni, T. E., Medici, V., Carlos, A. F., Davin, A., Ceretti, A., Mangieri, M., Cassini, P., Vaccaro, R., Zaccaria, D., Abbondanza, S., et al. (2020) · Journal of Visualized Experiments · doi:10.3791/60296 · Cited by 28
Sequence of proteome profiles in preclinical and symptomatic Alzheimer's disease
Li, X., Tsolis, K. C., Koper, M. J., Ronisz, A., Ospitalieri, S., von Arnim, C. A. F., Vandenberghe, R., Tousseyn, T., Scheuerle, A., Economou, A., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12345 · Cited by 27
Self-citationInsights into the pathological basis of dementia from population‐based neuropathology studies
Wharton, S. B., Simpson, J. E., Ince, P. G., Richardson, C. D., Merrick, R. L., Matthews, F. E., Brayne, C., & CFAS (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12923 · Cited by 27
Evaluating and treating neurobehavioral symptoms in professional American football players
Gardner, R. C., Possin, K. L., Hess, C. P., Huang, E. J., Grinberg, L. T., Nolan, A., Cohn‐Sheehy, B. I., Ghosh, P. M., Lanata, S., Merrilees, J. J., et al. (2015) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000157 · Cited by 27
Self-citationChronic Traumatic Encephalopathy and Neuropathological Comorbidities
Stein, T. D., & Crary, J. F. (2020) · Seminars in Neurology · doi:10.1055/s-0040-1713628 · Cited by 28
Self-citationThe Role of PERK in Understanding Development of Neurodegenerative Diseases
Smedley, G. D., Walker, K. E., & Yuan, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158146 · Cited by 27
Takamiya, A., Casteele, T. V., Koole, M. J. B., Winter, F. D., Bouckaert, F., den Stock, J. V., Sunaert, S. G., Dupont, P. J., Vandenberghe, R. R., Laere, K. V., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95206-0 · Cited by 27
TDP ‐43 Pathology Exacerbates Cognitive Decline in Primary Age‐Related Tauopathy
Smirnov, D. S., Salmon, D. P., Galasko, D. R., Edland, S. D., Pizzo, D. P., Goodwill, V., & Hiniker, A. O. (2022) · Annals of Neurology · doi:10.1002/ana.26438 · Cited by 27
Prevalence of chronic traumatic encephalopathy in the Sydney Brain Bank
McCann, H., Bahar, A. Y., Burkhardt, K., Gardner, A. J., Halliday, G. M., Iverson, G. L., & Shepherd, C. E. (2022) · Brain Communications · doi:10.1093/braincomms/fcac189 · Cited by 29
Kawakami, I., Iga, J., Takahashi, S., Lin, Y., & Fujishiro, H. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13485 · Cited by 27
Chen, X., Toueg, T. N., Harrison, T. M., Baker, S. L., & Jagust, W. J. (2023) · Annals of Neurology · doi:10.1002/ana.26813 · Cited by 27
Katsumata, Y., Wu, X., Aung, K. Z., Gauthreaux, K. M., Mock, C., Forrest, S. L., Kovács, G. G., & Nelson, P. T. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106412 · Cited by 27
Self-citationProgressive ataxia and palatal tremor: Two autopsy cases of a novel tauopathy
Gao, A. F., Faust‐Socher, A., Almurshed, M., Bigio, M. R. D., Lang, A. E., & Muñoz, D. G. (2017) · Movement Disorders · doi:10.1002/mds.27074 · Cited by 27
McMillan, C. T., Lee, E. B., Jefferson‐George, K., Naj, A. C., Deerlin, V. M. V., Trojanowski, J. Q., & Wolk, D. A. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.581 · Cited by 27
Self-citationFerrer, I. (2018) · Neuroglia · doi:10.3390/neuroglia1010010 · Cited by 27
Quantitative Assessment of Pathological Tau Burden in Essential Tremor: A Postmortem Study
Farrell, K. W., Cosentino, S., Iida, M. A., Chapman, S., Bennett, D. A., Faust, P. L., Louis, E. D., & Crary, J. F. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly104 · Cited by 27
Self-citationKropáčová, S., Mitterová, K., Klobušiaková, P., Brabenec, L., Anderková, Ľ., Elfmarková, N., Balážová, Z., Rektor, I., Grmela, R., Svobodová, L., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02068-y · Cited by 27
Influence of APOE genotype in primary age-related tauopathy
Robinson, A., Davidson, Y. S., Roncaroli, F., Minshull, J., Tinkler, P., Horan, M. A., Payton, A., Pendleton, N., & Mann, D. M. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01095-1 · Cited by 27
The Effects of Amyloid and Tau on Functional Network Connectivity in Older Populations
Wales, R. M., & Leung, H.-C. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0902 · Cited by 26
Walker, J. M., & Richardson, T. E. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac115 · Cited by 26
Anatomic survey of seeding in Alzheimer’s disease brains reveals unexpected patterns
Stopschinski, B. E., Del Tredici, K., Estill-Terpack, S.-J., Ghebremedhin, E., Yu, F. F., Braak, H., & Diamond, M. I. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01255-x · Cited by 26
Almeida, F., Santos, A. C., Jesus, T., Coelho, A., Quintas-Neves, M., Gauthreaux, K. M., Mock, C., Kukull, W. A., Crary, J. F., & Oliveira, T. G. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14191 · Cited by 28
Self-citationBrainbank Neuro-CEB Neuropathology Network, Thierry, M., Boluda, S., Delatour, B., Marty, S., Seilhean, D., Potier, M., & Duyckaerts, C. J. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02108-7 · Cited by 26
Saeed, U., Desmarais, P., & Masellis, M. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1956904 · Cited by 27
Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis
Jin, J., Su, D., Zhang, J., Li, X., & Feng, T. (2023) · Journal of Neurology · doi:10.1007/s00415-022-11556-3 · Cited by 26
Development, initial validation, and application of a visual read method for [ 18 F]MK‐6240 tau PET
Shuping, J., Matthews, D. C., Adamczuk, K., Scott, D., Rowe, C. C., Kreisl, W. C., Johnson, S. C., Lukic, A. S., Johnson, K. A., Rosa‐Neto, P., et al. (2023) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12372 · Cited by 26
Devi, G. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00015-6 · Cited by 27
Applications of tau PET imaging
Okamura, N., & Yanai, K. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.38 · Cited by 26
Fletcher, E. M., Filshtein, T. J., Harvey, D. J., Renaud, A., Mungas, D., DeCarli, C. S., & Initiative, A. D. N. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.04.001 · Cited by 26
Transmissibility versus Pathogenicity of Self-Propagating Protein Aggregates
Caughey, B. W., & Kraus, A. (2019) · Viruses · doi:10.3390/v11111044 · Cited by 26
Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
Zeydan, B., Lowe, V. J., Reichard, R. R., Przybelski, S. A., Lesnick, T. G., Schwarz, C. G., Senjem, M. L., Gunter, J. L., Parisi, J. E., Machulda, M. M., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25684 · Cited by 27
Self-citationGDAP2 mutations implicate susceptibility to cellular stress in a new form of cerebellar ataxia
Eidhof, I., Baets, J., Kamsteeg, E.-J., Deconinck, T., van Ninhuijs, L., Martin, J.-J., Schüle, R., Züchner, S., De Jonghe, P., Schenck, A., et al. (2018) · Brain · doi:10.1093/brain/awy198 · Cited by 25
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
Kadamangudi, S., Marcatti, M., Zhang, W.-R., Fracassi, A., Kayed, R., Limon, A., & Taglialatela, G. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02839-2 · Cited by 25
The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failure
Hardy, J., & Escott‐Price, V. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02911-7 · Cited by 25
Subramanian, S., Savanur, G., & Madhavadas, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.101 · Cited by 25
Kritikos, M., Clouston, S., Diminich, E. D., Deri, Y., Yang, X., Carr, M. A., Gandy, S., Sano, M. C., Bromet, E. J., & Luft, B. J. (2020) · Neurology and Therapy · doi:10.1007/s40120-020-00189-1 · Cited by 25
The Significance of Tau Aggregates in the Human Brain
Castellani, R. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120972 · Cited by 25
Provost, K., Iaccarino, L., Soleimani‐Meigooni, D. N., Baker, S. L., Edwards, L., Eichenlaub, U., Hansson, O., Jagust, W. J., Janabi, M., Joie, R. L., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05152-8 · Cited by 27
Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults
Guo, T., Landau, S. M., Jagust, W. J., & Initiative, A. D. N. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00913-5 · Cited by 25
Genetic Architecture of Primary Tauopathies
Gallo, D., Ruiz, A., & Sánchez‐Juan, P. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.022 · Cited by 25
Gelpí, E., Baiardi, S., Nos, C., Dellavalle, S., Aldecoa, I., Ruiz‐García, R., Ispierto, L., Escudero, D., Casado, V., Barranco, E., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01415-7 · Cited by 25
Oberstein, T. J., Schmidt, M. A., Florvaag, A., Haas, A.-L., Siegmann, E.-M., Olm, P., Utz, J., Spitzer, P., Doerfler, A., Lewczuk, P., et al. (2022) · Brain · doi:10.1093/brain/awac297 · Cited by 25
Defining the phenotypic spectrum of sporadic Creutzfeldt–Jakob disease MV2K: the kuru plaque type
Baiardi, S., Mammana, A., Dellavalle, S., Rossi, M., Redaelli, V., Colaizzo, E., Fede, G. D., Ladogana, A., Capellari, S., & Parchi, P. (2023) · Brain · doi:10.1093/brain/awad074 · Cited by 25
Tau accumulation and atrophy predict amyloid independent cognitive decline in aging
Fonseca, C. S., Baker, S. L., Dobyns, L., Janabi, M., Jagust, W. J., & Harrison, T. M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13654 · Cited by 25
Ageing-Related Neurodegeneration and Cognitive Decline
Alafuzoff, I. I., & Libard, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074065 · Cited by 27
Self-citationMaggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25
Neuropathological findings in multiple system atrophy with cognitive impairment
Jellinger, K. A. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02201-2 · Cited by 25
Self-citationRisk for Misdiagnosing Chronic Traumatic Encephalopathy in Men With Anger Control Problems
Iverson, G. L., & Gardner, A. J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00739 · Cited by 25
Ohm, D. T., Peterson, C. S., Lobrovich, R., Cousins, K. A. Q., Gibbons, G. S., McMillan, C. T., Wolk, D. A., Deerlin, V. M. V., Elman, L. B., Spindler, M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02210-1 · Cited by 26
Self-citationUtility of Plasma Neurofilament Light in the 1Florida Alzheimer’s Disease Research Center (ADRC)
Barker, W., Quinonez, C., Greig, M. T., Behar, R., Chirinos, C. L., Rodriguez, R. A., Rosselli, M., Rodriguez, M. J., Curiel, R. E., Rundek, T., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200901 · Cited by 25
Gefen, T. D., Kawles, A., Makowski‐Woidan, B., Engelmeyer, J., Ayala, I. A. D. L., Abbassian, P., Zhang, H., Weıntraub, S., Flanagan, M. E., Mao, Q., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhaa409 · Cited by 25
Self-citationPassive immunization against phosphorylated tau improves features of Huntington's disease pathology
Alpaugh, M., Masnata, M., de Rus Jacquet, A., Lepinay, E., Denis, H. L., Saint-Pierre, M., Davies, P., Planel, E., & Cicchetti, F. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.020 · Cited by 25
Thal, D. R., Ronisz, A., Tousseyn, T., Upadhaya, A. R., Balakrishnan, K., Vandenberghe, R. R., Vandenbulcke, M., Arnim, C. A. F. V., Otto, M., Beach, T. G., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01005-5 · Cited by 25
Self-citationQi, C., Kobayashi, R., Kawakatsu, S., Kametani, F., Scheres, S. H. W., Goedert, M., & Hasegawa, M. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02741-x · Cited by 24
Takenoshita, N., Shimizu, S., Kanetaka, H., Sakurai, H., Suzuki, R., Miwa, T., Odawara, M., Ishii, K., Shimada, H., Higuchi, M., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190620 · Cited by 24
Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 24
The many faces of globular glial tauopathy: A clinical and imaging study
Buciuc, M., Koga, S., Pham, N. T. T., Duffy, J. R., Knopman, D. S., Ali, F., Boeve, B. F., Graff‐Radford, J., Botha, H., Lowe, V. J., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15603 · Cited by 24
Self-citationAlzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25
Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease
Wisse, L. E. M., Wuestefeld, A., Murray, M. E., Jagust, W. J., & Joie, R. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14582 · Cited by 24
Self-citationThe science and questions surrounding chronic traumatic encephalopathy
Ban, V. S., Madden, C. J., Bailes, J. E., Batjer, H. H., & Lonser, R. R. (2016) · Neurosurgical FOCUS · doi:10.3171/2016.2.focus15609 · Cited by 24
The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy
Makinde, H. M., Just, T. B., Cuda, C. M., Perlman, H., & Schwulst, S. J. (2017) · Shock · doi:10.1097/shk.0000000000000859 · Cited by 24
Lafirdeen, A. S. M., Cognat, E., Sabia, S., Hourrègue, C., Lilamand, M., Dugravot, A., Bouaziz-Amar, É., Laplanche, J., Hugon, J., Singh‐Manoux, A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217026 · Cited by 24
Rossi, M., Kai, H., Baiardi, S., Bartoletti‐Stella, A., Carlà, B., Zenesini, C., Capellari, S., Kitamoto, T., & Parchi, P. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0706-6 · Cited by 24
Miki, T., Yokota, O., Haraguchi, T., Ishizu, H., Hasegawa, M., Ishihara, T., Ueno, S., Takenoshita, S., Terada, S., & Yamada, N. (2020) · Brain Pathology · doi:10.1111/bpa.12843 · Cited by 24
Quantitative Assessment of Hippocampal Tau Pathology in AD and PART
Zhang, L., Jiang, Y., Zhu, J., Liang, H., He, X., Qian, J., Lin, H. B., Tao, Y., & Zhu, K. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01573-0 · Cited by 24
Pearson, A., Ajoy, R., Crynen, G. C., Reed, J. M., Algamal, M., MULLAN, M. J., Purohit, D. P., Crawford, F., & Ojo, J. O. (2020) · BMC Neurology · doi:10.1186/s12883-020-01849-3 · Cited by 24
Davis, D. A., Garamszegi, S. P., Banack, S. A., Dooley, P. D., Coyne, T. M., McLean, D. W., Rotstein, D. S., Mash, D. C., & Cox, P. A. (2021) · Toxins · doi:10.3390/toxins13100697 · Cited by 24
Molecular signatures of resilience to Alzheimer’s disease in neocortical layer 4 neurons
Dharshini, S. A. P., Sanz‐Ros, J., Pan, J., Tang, W., Vallejo, K., Liu, Y. C., Otero‐García, M., & Cobos, I. (2026) · Nature Communications · doi:10.1038/s41467-026-68920-4 · Cited by 23
Taylor, W. D., Boyd, B. D., Turner, R. M., McQuoid, D. R., Ashley‐Koch, A. E., MacFall, J. R., Saleh, A., & Potter, G. G. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9522-9 · Cited by 23
Christensen, K. R., Beach, T. G., Serrano, G. E., & Kanaan, N. M. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0675-9 · Cited by 23
Self-citationNosheny, R. L., Insel, P. S., Mattsson, N., Tosun, D., Buckley, S. T., Truran, D., Schuff, N. W., Aisen, P. S. S., & Weiner, M. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.07.005 · Cited by 23
Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity
Koller, E. J., & Chakrabarty, P. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00151 · Cited by 23
Tau pathology mediates age effects on medial temporal lobe structure
Wisse, L. E. M., Xie, L., Das, S. R., de Florès, R., Hansson, O., Habes, M., Doshi, J. J., Davatzikos, C. A., Yushkevich, P. A., & Wolk, D. A. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.09.017 · Cited by 23
Mesial temporal tau in amyloid-β-negative cognitively normal older persons
Krishnadas, N., Doré, V., Groot, C., Lamb, F., Bourgeat, P., Burnham, S. C., Huang, K., Goh, A., Masters, C. L., Villemagne, V. L., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00993-x · Cited by 23
The Complexity of Subjective Cognitive Decline
Ossenkoppele, R., & Jagust, W. J. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2224 · Cited by 23
Panza, F., Dibello, V., Sardone, R., Castellana, F., Zupo, R., Lampignano, L., Bortone, I., Stallone, R., Cirillo, N., Damiani, C., et al. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2233892 · Cited by 22
Jury-Garfe, N., Redding-Ochoa, J., You, Y., Martínez, P., Karahan, H., Chimal-Juárez, E., Johnson, T. S., Zhang, J., Resnick, S., Kim, J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02775-1 · Cited by 22
“Alpha-synuclein lesions were evaluated according to the methods of McKeith et al. [61] and primary age-related tauopathy (PART) as described in Crary et al. [16].”
MethodSelf-citationRichardson, T. E., Walker, J. M., Farrell, K. W., Oliveira, T. G., White, C. L., & Crary, J. F. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02943-x · Cited by 25
Self-citationTaddei, R. N., Sanchez-Mico, M. V., Bonnar, O., Connors, T. R., Gaona, A., Denbow, D., Frosch, M. P., & Gómez‐Isla, T. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01370-3 · Cited by 23
Rodríguez, J. L., Oltmer, J., Marshall, M., Champion, S. N., Frosch, M. P., & Augustinack, J. C. (2023) · Brain Pathology · doi:10.1111/bpa.13159 · Cited by 22
Blood β‐synuclein is related to amyloid PET positivity in memory clinic patients
Oeckl, P., Blūma, M., Bucci, M., Halbgebauer, S., Chiotis, K., Matton, A., Ashton, N. J., Molfetta, G. D., Grötschel, L., Kivipelto, M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13046 · Cited by 22
The clinical importance of suspected non-Alzheimer disease pathophysiology
Vos, S. J. B., Delvenne, A., Jack, C. R., Thal, D. R., & Visser, P. J. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00962-y · Cited by 23
Self-citationRoher, A. E., Maarouf, C. L., & Kokjohn, T. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150757 · Cited by 22
Koss, D. J., Dubini, M., Buchanan, H. M., Hull, C. E., & Platt, B. (2018) · Brain Research · doi:10.1016/j.brainres.2018.08.014 · Cited by 22
Olofsson, H. E., & Englund, E. M. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12552 · Cited by 22
Idland, A., Sala‐Llonch, R., Watne, L. O., Brækhus, A., Hansson, O., Blennow, K., Zetterberg, H., Sørensen, Ø., Walhovd, K. B., Wyller, T. B., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.04.002 · Cited by 22
Rosa, G., Giannotti, C., Martella, L. A., Massa, F., Serafini, G., Pardini, M., Nobili, F. M., & Monacelli, F. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191075 · Cited by 23
Eckerström, C., Svensson, J., Kettunen, P., Jonsson, M. A. G., & Eckerström, M. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12031 · Cited by 22
Karanth, S. D., Schmitt, F. A., Nelson, P. T., Katsumata, Y., Kryscio, R. J., Fardo, D. W., Harp, J. P., & Abner, E. L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210293 · Cited by 22
Self-citationDistinct Factors Drive the Spatiotemporal Progression of Tau Pathology in Older Adults
Adams, J. N., Harrison, T. M., Maass, A., Baker, S. L., & Jagust, W. J. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1601-21.2021 · Cited by 22
Clinician-judged hearing impairment and associations with neuropathologic burden
Brenowitz, W. D., Besser, L. M., Kukull, W. A., Keene, C. D., Glymour, M. M., & Yaffe, K. S. (2020) · Neurology · doi:10.1212/wnl.0000000000010575 · Cited by 22
Self-citationAlrouji, M., Alshammari, M. S., Syed, T., & Shamsi, A. (2025) · Antioxidants · doi:10.3390/antiox14070774 · Cited by 21
Advances in PET imaging of protein aggregates associated with neurodegenerative disease
Higuchi, M., Tagai, K., Takahata, K., & Endo, H. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01126-2 · Cited by 21
Metadata
- Authors
- Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Gearing, M., Grinberg, L. T., Hof, P. R., Hyman, B. T., Jellinger, K., Jicha, G. A., Kovacs, G. G., Knopman, D. S., Kofler, J., Kukull, W. A., Mackenzie, I. R., Masliah, E., McKee, A., Montine, T. J., Murray, M. E., Neltner, J. H., Santa-Maria, I., Seeley, W. W., Serrano-Pozo, A., Shelanski, M. L., Stein, T., Takao, M., Thal, D. R., Toledo, J. B., Troncoso, J. C., Vonsattel, J. P., White, C. L., Wisniewski, T., Woltjer, R. L., Yamada, M., & Nelson, P. T.
- Affiliations
- Columbia University Irving Medical Center (US)
- University of Pennsylvania (US)
- Rush University Medical Center (US)
- University of Kentucky (US)
- Uppsala University (SE)
- Newcastle University (GB)
- Banner Sun Health Research Institute (US)
- Northwestern University (US)
- Washington University in St. Louis (US)
- Mayo Clinic (US)
- Emory University (US)
- Universidade de São Paulo (BR)
- Icahn School of Medicine at Mount Sinai (US)
- Harvard University (US)
- University of Pittsburgh Medical Center (US)
- University of Washington (US)
- University of British Columbia (CA)
- University of California San Diego (US)
- Boston University (US)
- University of California, San Francisco (US)
- Tokyo Metropolitan Geriatric Hospital (JP)
- Universität Ulm (DE)
- The University of Texas Southwestern Medical Center (US)
- Oregon Health & Science University (US)
- Kanazawa University (JP)
- Corresponding author
- Crary, John F.
- Nelson, Peter T.
- ORCID
- Crary, John F.
- Trojanowski, John Q.
- Schneider, Julie A.
- Abisambra, Jose F.
- Abner, Erin L.
- Alafuzoff, Irina
- Arnold, Steven E.
- Attems, Johannes
- Beach, Thomas G.
- Bigio, Eileen H.
- Dickson, Dennis W.
- Gearing, Marla
- Grinberg, Lea T.
- Hof, Patrick R.
- Hyman, Bradley T.
- Jellinger, Kurt
- Jicha, Gregory A.
- Knopman, David S.
- Kofler, Julia
- Kukull, Walter A.
- Mackenzie, Ian R.
- Masliah, Eliezer
- McKee, Ann
- Montine, Thomas J.
- Murray, Melissa E.
- Neltner, Janna H.
- Seeley, William W.
- Shelanski, Michael L.
- Stein, Thor
- Takao, Masaki
- Thal, Dietmar R.
- Troncoso, Juan C.
- White, Charles L.
- Woltjer, Randall L.
- Yamada, Masahito
- Nelson, Peter T.
- Venue
- Acta Neuropathologica
- Published
- 2014-10-28
- Volume
- 128
- Issue
- 6
- Pages
- 755-766
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4257842
- OpenAlex
- W1971032265
- Cited by
- 1,467
- References
- 160
- Citations by year
- 2026: 85 · 2025: 126 · 2024: 154 · 2023: 123 · 2022: 154 · 2021: 142 · 2020: 143 · 2019: 131 · 2018: 107 · 2017: 119 · 2016: 105 · 2015: 68 · 2014: 9
- FWCI
- 66.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Alzheimer's Association (P30 AG013854, P30AG010124, P01 AG003991, P50 AG025688, P50 AG005681, NIRG-11-204450, P50 AG005136, P50 AG005146)
- BrightFocus Foundation (U01 AG006786, P50 AG016574, P50 AG005136)
- Mayo Foundation for Medical Education and Research (AG016574)
- Alzheimer Forschung Initiative (#13803)
- Alzheimer's Society (AS-PG-2013-011)
- National Institute for Health and Care Research
- Bundesministerium für Bildung und Forschung
- National Institutes of Health (AG028 383, 5r01ag038651-10, AG016574, AG010124, AG005138, AG005133, AG005131, AG008051, AG005681, AG019610, AG003991, AG013854, AG025688, AG003949, AG005136, AG011378)
- Medical Research Council (G0400074, U01 AG006786)
- Japan Society for the Promotion of Science (26430060)
- National Institute on Aging (AG008051, R01‐AG038651, R01AG037212, P30AG028383, P01AG007232, P30AG012300, R37AG018440, P50AG005133, AG184440, U01AG016976, P50AG005131, P50AG005138, U01AG006786, P01AG003949, P30AG010124, AG005131, R01AG011378, P30AG008051, P50AG008702, P50AG005681, P30AG036453, P30AG019610, P50AG005146, P01AG003991, P30AG013846, P50AG005136, P30AG013854, P50AG025688, R01AG041851, P01AG002219, P01AG019724, P50AG016574)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- primary age-related tauopathy, neurofibrillary tangles, tau pathology, Alzheimer's disease, nomenclature, temporal lobe atrophy, tau biomarkers, tau imaging, brain aging, cognitive impairment
- MeSH terms
- Aging, Brain, Diagnosis, Differential, Humans, Terminology as Topic, Tauopathies, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
